Low-density lipoprotein cholesterol levels and adverse clinical outcomes in chronic kidney disease: Results from the KNOW-CKD

The optimal low-density lipoprotein cholesterol (LDL-C) level to prevent cardiovascular disease in chronic kidney disease (CKD) patients remains unknown. This study aimed to explore the association of LDL-C levels with adverse cardiovascular and kidney outcomes in Korean CKD patients and determine t...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Nutrition, metabolism, and cardiovascular diseases metabolism, and cardiovascular diseases, 2022-02, Vol.32 (2), p.410-419
Hauptverfasser: Lee, Changhyun, Park, Jung Tak, Chang, Tae-Ik, Kang, Ea Wha, Nam, Ki Heon, Joo, Young Su, Sung, Su-Ah, Kim, Yeong Hoon, Chae, Dong-Wan, Park, Su Kyung, Ahn, Curie, Oh, Kook-Hwan, Yoo, Tae-Hyun, Kang, Shin-Wook, Han, Seung Hyeok
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The optimal low-density lipoprotein cholesterol (LDL-C) level to prevent cardiovascular disease in chronic kidney disease (CKD) patients remains unknown. This study aimed to explore the association of LDL-C levels with adverse cardiovascular and kidney outcomes in Korean CKD patients and determine the validity of “the lower, the better” strategy for statin intake. A total of 1886 patients from the KoreaN cohort study for Outcome in patients With CKD (KNOW-CKD) were included. Patients were classified into four LDL-C categories:
ISSN:0939-4753
1590-3729
DOI:10.1016/j.numecd.2021.09.037